IP Library Granted Patent US 10,852,311
Granted Patent B2
US 10,852,311 · App. 15/648,029 · Granted Dec 1, 2020

Additive channels

Inventors: Daniel Levner (Brookline, MA); Christopher David Hinojosa (Cambridge, MA); Norman Wen (West Roxbury, MA); Jacob Fraser (Somerville, MA); Justin Nguyen (Medford, MA); Riccardo Barrile (Boston, MA); Geraldine Hamilton (Boston, MA); Catherine Karalis (Brookline, MA); Hyoungshin Park (Newton, MA); Antonio Varone (West Roxbury, MA); Andries Van der Meer (Enchede, NL); Monicah Otieno (Robbinville, NJ); David Conegliano (Boston, MA)
Assignee: Emulate, Inc.
G01N33/86B01L3/5023B01L3/502707B01L3/502715B01L3/502746B01L3/502761C12M23/16C12M29/00C12M29/04C12M29/10C12M35/08C12M41/46G01N33/54366G01N33/80B01L2200/02B01L2200/027B01L2200/0605B01L2200/0647B01L2200/16B01L2300/0809B01L2300/0816B01L2300/0867B01L2300/0883B01L2300/0887B01L2300/14B01L2300/16G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,852,311
App. No.
15/648,029
Granted
Dec 1, 2020
Kind
B2
Abstract

Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

Claims (31)

1. A method of adding reagent to a fluid sample in a microfluidic device, comprising:

a) providing

i) a fluid sample comprising a first anticoagulant, and

ii) a micro fluidic device comprising a microchannel comprising first and second sides and first and second ends, an input port in fluidic communication with said first end of said microchannel, and first and second additive channels in fluidic communication with said a first end of said microchannel, said first additive channels positioned on said first side of said microchannel near said input port, said second additive channel positioned on said second side of said microchannel near said input port, said first and second additive channels comprising

iii) a first reagent solution comprising one or more reagents capable of re-activating a coagulation cascade,

said microfluidic device further comprising one or more additional additive channels in fluidic communication with said second end of said microchannel,

said one or more additional additive channels comprising

iv) a second reagent solution comprising a second anticoagulant;

b) introducing said fluid sample into said microchannel of said microfluidic device under conditions such that a portion of said fluid sample contacts said first reagent solution as said fluid sample moves through said microchannel so as to create a treated portion; and

c) contacting said treated portion with said second reagent solution.

2. The method of claim 1 , wherein said fluid sample comprises platelets.

3. The method of claim 2 , wherein said fluid sample is blood.

4. The method of claim 3 , wherein said blood is human blood.

5. The method of claim 4 , wherein said first anticoagulant was added to said human blood at the time it was collected from said human.

6. The method of claim 1 , wherein said introducing of step b) is through said input port.

7. The method of claim 6 , wherein said first and second additive channels are positioned at said input port.

8. The method of claim 1 , wherein said at least one microchannel comprises an active region comprising cells.

9. The method of claim 8 , wherein said cells are living cells.

10. The method of claim 8 , wherein said cells are fixed cells.

11. The method of claim 8 , wherein said cells comprise endothelial cells.

12. The method of claim 11 , wherein said endothelial cells are vascular endothelial cells.

13. The method of claim 12 , wherein said vascular endothelial cells are a monolayer.

14. The method of claim 13 , wherein said monolayer is disposed on a membrane.

15. The method of claim 13 , wherein said monolayer is attached to a cell adhesion promoting substance that coats the microchannel.

16. The method of claim 15 , wherein said cell adhesion promoting substance comprises one or more ECM proteins.

17. The method of claim 1 , wherein said first reagent solution comprises calcium and magnesium.

18. The method of claim 1 , wherein said second reagent solution comprises ethylenediamine tetraacetic acid (EDTA).

19. The method of claim 1 , wherein said microfluidic device comprises an output port in fluidic communication with said microchannel at said second end.

20. The method of claim 19 , wherein said one or more additive channels are positioned at or near said output port.

21. The method of claim 20 , wherein one or more additional additive channels are positioned on one side of said microchannel near said output port.

22. The method of claim 21 , wherein one or more additional additive channels are positioned on another side of said microchannel near said output port.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2020
From: JANSSEN BIOTECH, INC.
To: EMULATE, INC.
Reel/Frame 054150/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2018
From: LEVNER, DANIEL; HINOJOSA, CHRISTOPHER DAVID; WEN, NORMAN; FRASER, JACOB; NGUYEN, JUSTIN; BARRILE, RICCARDO; HAMILTON, GERALDINE; KARALIS, CATHERINE; PARK, HYOUNG SHIN; VARONE, ANTONIO; VAN DER MEER, ANDRIES; OTIENO, MONICAH; CONEGLIANO, DAVID
To: EMULATE, INC.; JANSSEN BIOTECH, INC.
Reel/Frame 045930/0151 →
Continuity (2)
Provisional Application 62361274 · Jul 12, 2016
Related Publication 20180017583A1 · Jan 18, 2018
Cited By (1)
US 1,106,481